Skip to main content

Table 4 Results from multiple regression models: A) Physical health-related quality of life (HRQoL) regressed on body mass index and mental HRQoL. B) Relative risk of cardiovascular disease regressed on age, gender, clozapine medication and antipsychotic dosage

From: Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study

 

b

SE

Beta

p

Adjusted R2

A) PCS regressed on:

 BMI (kg/m2)

−0.516

0.203

−0.272

.013

 

 MCS

0.167

0.079

0.226

.038

 

 Constant

50.918

6.025

 

< .001

 
     

.091

(p = .009)

B) CVD relative risk regressed on:

 Prescribed DDD

0.198

0.063

0.283

.002

 

 On clozapine

0.523

0.175

0.263

.004

 

 Age (years)

−0.030

0.008

−0.346

< .001

 

 Gender (male = 1)

−0.364

0.138

−0.238

.010

 

 Constant

1.751

0.515

 

.001

 
     

.399

(p < .001)

  1. b unstandardized regression coefficient, Beta standardized regression coefficient, SE standard error, BMI body mass index, CVD cardiovascular disease, DDD daily defined dose, MCS mental component score, PCS physical component score